Login / Signup

PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge.

Thomas SouthworthSarah MasonAlan BellIsabel RamisMarta CalbetAnna DomenechNeus PratsMontserrat MiralpeixDave Singh
Published in: Biomarker research (2018)
Future clinical trials of novel kinase inhibitors could use the allergen challenge model in proof of concept studies, while employing these biomarkers to investigate pharmacological inhibition in the lungs.
Keyphrases
  • allergic rhinitis
  • clinical trial
  • chronic obstructive pulmonary disease
  • lung function
  • randomized controlled trial
  • cystic fibrosis
  • study protocol